Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04421820
Title BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bold Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | CAN

Facility Status City State Zip Country Details
University of California, Los Angeles Santa Monica California 90095 United States Details
Moffitt Cancer Center Tampa Florida 33612 United States Details
Cross Cancer Institue Edmonton Alberta Canada Details
Juravinski Cancer Centre Hamilton Ontario Canada Details
The Ottawa Hospital Cancer Centre Ottawa Ontario Canada Details
Princess Margaret Cancer Centre Toronto Ontario Canada Details
Jewish General Hospital Montreal Quebec Canada Details
McGill University Health Centre Glen Site Montréal Quebec Canada Details
National Cancer Center Goyang Korea, Republic of Details
Kangbuk Samsung Hospital Seoul Korea, Republic of Details
Samsung Medical Center Seoul Korea, Republic of Details
Seoul National University Hospital Seoul Korea, Republic of Details
Severance Hospital - Yonsei University Seoul Korea, Republic of Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field